Synergistic tumor treatment with extended-PK IL-2 and therapeutic agents
US9844582B2 · kind B2 · utility
34Cited by
11References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 21, 2013 |
| Grant date | Dec 19, 2017 |
| Priority date | — |
| Expiry date | May 21, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods of treating cancer with a combination of extended-PK IL-2 and one or more therapeutic agents, such as a therapeutic antibody. The methods of the invention are applicable across any type of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.